Environment, mitochondria, and Parkinson's disease

Neuroscientist

Volumn 8, Issue 3, 2002, Pages 192-197

  Sherer, Todd B ^a   Betarbet, Ranjita ^a   Greenamyre, J Timothy ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxicity; Neurodegeneration; Oxidative stress; Pesticides

Indexed keywords

PESTICIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); WELL WATER;

AGRICULTURE; BRAIN MITOCHONDRION; CLINICAL FEATURE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RURAL AREA; STRIATONIGRAL DEGENERATION;

EID: 0036100742     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073858402008003004     Document Type: Review

References (43)

1. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
2. Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra
3. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
4. The rotenone model of Parkinson's disease in vitro: Progressive oxidative damage, caspase-3 activation and apoptosis
5. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
6. Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease
7. Inhibitors of NADH-ubiquinone reductase: An overview
8. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
9. Alpha-synuclein gene haplotypes are associated with Parkinson's disease
10. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions
11. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease
12. Response: Parkinson's disease, pesticides and mitochondrial dysfunction
13. Bioenergetics and glutamate excitotoxicity
14. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
15. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles
16. Interaction of alpha-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site
17. Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP
18. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
19. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
20. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
21. Pesticides and Parkinson's disease
22. Complex I inhibitors as insecticides and acaricides
23. Novel free radical spin traps protect against malonate and MPTP neurotoxicity
24. Parkinson's disease, pesticides, and glutathione transferase polymorphisms
25. Neuropathology of movement disorders: An overview
26. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
27. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
28. Abnormalities of the electron transport chain in idiopathic Parkinson's disease
29. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
30. Environmental risk factors and Parkinson's disease: A metaanalysis
31. A meta-analysis of Parkinson's disease and exposure to pesticides
32. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection
33. Human complex I defects in neurodegenerative diseases
34. Mitochondrial complex I deficiency in Parkinson's disease
35. The rotenone model of Parkinson's disease in vivo: Selective striatal oxidative damage and caspase-3 activation in nigrostriatal neurons
36. Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells
37. Dityrosine crosslinking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies
38. Alpha-synuclein in Lewy bodies
39. Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice
40. Origin and functional consequences of the complex I defect in Parkinson's disease
41. In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone
42. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP
43. Positron emission tomographic evidence for proression of human MPTP-induced dopaminergic lesions